Noven To Present At Barclays Capital Global Healthcare Conference

-- Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) today announced that Peter Brandt, Noven’s President & Chief Executive Officer, is scheduled to present an update on Noven’s business and prospects at the Barclays Capital Global Healthcare Conference in Miami Beach on Wednesday, March 11th at 11:15 a.m. ET. The presentation will be webcast live at, and a rebroadcast will be available thereafter for at least two weeks at the same site.

Noven Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products. Noven’s business and operations are focused in three principal areas – transdermal drug delivery, the Novogyne joint venture, and Noven Therapeutics, Noven’s specialty pharmaceutical unit. For more information about Noven Pharmaceuticals, visit

Alina Bowman
Investor Relations Coordinator